Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Allarity Therapeutics, Inc. (ALLR) just unveiled an update.
Allarity Therapeutics, Inc. has transitioned from a consultancy agreement to a Management Services Agreement (MSA) with Ljungaskog Consulting AB, led by CEO Thomas H. Jensen. Under this new MSA effective June 1, 2024, Jensen will continue his CEO duties for a monthly fee of $43,750, with the potential for performance-based compensation adjustments. The agreement includes a $100,000 signing bonus, with provisions for its repayment under certain conditions, and allows for discretionary performance bonuses and expense reimbursements. The agreement outlines specific terms for termination by either party, with defined consequences and payments due upon such occurrences.
For detailed information about ALLR stock, go to TipRanks’ Stock Analysis page.